AI assistant
Traws Pharma, Inc. — Director's Dealing 2013
Jul 25, 2013
35199_dirs_2013-07-24_ea8b3a67-a5d6-43dc-9b1d-cf04c2753408.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24
Reporting Person: Altland James (SVP, Finance & Corp. Develop.)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to purchase) | $6.00 | 2017-08-01 | Common Stock (60015) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2020-03-17 | Common Stock (3750) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2020-03-17 | Common Stock (15003) | Direct | |
| Stock Option (right to purchase) | $6.13 | 2020-12-10 | Common Stock (11252) | Direct | |
| Stock Option (right to purchase) | $6.13 | 2021-12-05 | Common Stock (2960) | Direct | |
| Stock Option (right to purchase) | $13.28 | 2022-12-19 | Common Stock (3750) | Direct | |
| Stock Option (right to purchase) | $13.28 | 2022-12-19 | Common Stock (18754) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 15,003 shares of Common Stock, is immediately exercisable and vests over 4 years from March 17, 2010, with 25% vesting on March 17, 2011 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
F2: This option, representing a right to purchase a total of 18,754 shares of Common Stock, is immediately exercisable and vests over 4 years from December 18, 2012, 25% vesting on December 18, 2013 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.